Of course, then the 2,000 would not get treatments. There is no free lunch and when government makes approvals cost hundreds of millions, those costs will get paid or the work will not be done.
If the company is developing the drug through approval, I agree.
But RTRX isn't developing anything. They're just rent seeking on the backs of patients.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.